Antidepressants and antipsychotics
Evidence from five randomised controlled trials were identified for antidepressants. Three trials (single trials on the serotonin-norepinephrine reuptake inhibitor (SNRI) duloxetine hydrochloride, the monoamine oxidase inhibitor (MAOI) moclobemide, and the selective serotonin reuptake inhibitor (SSRI) fluoxetine) were compared only to placebo. One trial had four arms comparing fluoxetine and exercise control, graded exercise and placebo, fluoxetine and graded exercise, and placebo and exercise control. One trial compared fluoxetine to amisulpride (an atypical antipsychotic). All the evidence very low quality and the majority was based on single small studies. No evidence was identified for mortality, cognitive function, sleep quality, activity levels, return to school/work, exercise performance measures, care needs and impact on families and carers